Inventor · disambiguated record
Brahmam Pujala
Also filed as: PUJALA BRAHMAM
21 granted patents·29 pending applications·30 citations·filing 2014–2024
91Inventor score
Files withNUVATION BIO INC16Praxis Biotech LLC15MEDIVATION TECH LLC5BLACK BELT TX LTD3INTEGRAL BIOSCIENCES PRIVATE LTD3
Top patents by PatentIndex Score
50 records- 0190US11292782B2Diarylhydantoin compounds and methods of use thereofNUVATION BIO INC·Filed 2019·Granted Apr 5, 2022·6 cites·39 claims
- 0290US11034669B2Pyrrole and pyrazole compounds and methods of use thereofNUVATION BIO INC·Filed 2019·Granted Jun 15, 2021·6 cites·16 claims
- 0382US12325702B2ATF6 inhibitors and uses thereofALTOS LABS INC·Filed 2023·Granted Jun 10, 2025·1 cites·38 claims
- 0482US10030004B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2014·Granted Jul 24, 2018·6 cites·10 claims
- 0581US11166942B2Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2019·Granted Nov 9, 2021·2 cites·42 claims
- 0681US10807994B2Heterocyclic compounds and uses thereofNUVATION BIO INC·Filed 2018·Granted Oct 20, 2020·3 cites·59 claims
- 0779US11504364B2Inhibitors of fibroblast activation proteinPraxis Biotech LLC·Filed 2019·Granted Nov 22, 2022·2 cites·37 claims
- 0876US11174252B2Heterocyclic compounds as kinase inhibitorsNUVATION BIO INC·Filed 2019·Granted Nov 16, 2021·1 cites·106 claims
- 0975US11053216B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2019·Granted Jul 6, 2021·0 cites·19 claims
- 1073US11702401B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2021·Granted Jul 18, 2023·0 cites·26 claims
- 1171US12325720B2Ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and uses thereof1CBIO INC·Filed 2024·Granted Jun 10, 2025·0 cites·11 claims
- 1270US10829485B2ATF6 inhibitors and uses thereofBLACK BELT TX LTD·Filed 2019·Granted Nov 10, 2020·1 cites·60 claims
- 1369US9670172B2Heterocyclic compounds and methods of useMEDIVATION TECHNOLOGIES INC·Filed 2014·Granted Jun 6, 2017·2 cites·36 claims
- 1464US2023144841A1Inhibitors of fibroblast activation proteinPraxis Biotech LLC·Filed 2022·Application pending·0 cites
- 1564US2023118115A1SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS WEE1 INHIBITORSNUVATION BIO INC·Filed 2022·Application pending·0 cites
- 1663US2023109104A1Heterocyclic compounds and uses thereofNUVATION BIO INC·Filed 2022·Application pending·0 cites
- 1761US2022135598A1Ectonucleotide pyrophosphatase-phosphodiesterase-1 (enpp1) inhibitors and uses thereofINTEGRAL BIOSCIENCES PRIVATE LTD·Filed 2021·Application pending·0 cites
- 1860US2022071966A1Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2021·Application pending·0 cites
- 1960US2023062022A1Heterocyclic compounds as kinase inhibitorsNUVATION BIO INC·Filed 2021·Application pending·0 cites
- 2058US2023083885A1Modulators of integrated stress response pathwayPraxis Biotech LLC·Filed 2022·Application pending·0 cites
- 2158US2023047589A1Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2021·Application pending·0 cites
- 2257US10501436B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2018·Granted Dec 10, 2019·0 cites·21 claims
- 2356US11332473B2Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitorsNUVATION BIO INC·Filed 2020·Granted May 17, 2022·0 cites·60 claims
- 2456US2023042881A1Modulators of integrated stress response pathwayPraxis Biotech LLC·Filed 2022·Application pending·0 cites
- 2554US11230542B2Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2018·Granted Jan 25, 2022·0 cites·58 claims
- 2653US11299493B2Heterocyclic compounds and uses thereofNUVATION BIO INC·Filed 2018·Granted Apr 12, 2022·0 cites·34 claims
- 2753US2021221803A1Atf6 inhibitors and uses thereofBLACK BELT TX LTD·Filed 2020·Application pending·0 cites
- 2851US2025346587A1Nitrogen-containing five-membered heterocyclic derivatives as checkpoint kinase 1 inhibitor and uses thereofSPEROGENIX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 2950US2022363662A1Compounds as lxr agonistsINTEGRAL BIOSCIENCES PRIVATED LTD·Filed 2022·Application pending·0 cites
- 3050US2022162229A1Heterocyclic compounds and uses thereofNUVATION BIO INC·Filed 2020·Application pending·0 cites
- 3150US2021317102A1Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2020·Application pending·0 cites
- 3249US2022347187A1Heterocyclic compounds as kinase inhibitorsNUVATION BIO INC·Filed 2020·Application pending·0 cites
- 3349US2022273659A1Heterocyclic compounds as kinase inhibitorsNUVATION BIO INC·Filed 2020·Application pending·0 cites
- 3448US2022281859A1Heterocyclic compounds as kinase inhibitorsNUVATION BIO INC·Filed 2020·Application pending·0 cites
- 3548US2023143059A1Gcn2 modulator compoundsAlesta Therapeutics BV·Filed 2021·Application pending·0 cites
- 3647US2022220115A1Heterocyclic compounds and uses thereofNUVATION BIO INC·Filed 2020·Application pending·0 cites
- 3747US2023028584A1Atf6 modulators and uses thereofPraxis Biotech LLC·Filed 2020·Application pending·0 cites
- 3847US2020270232A1Inhibitors of integrated stress response pathwayPraxis Biotech LLC·Filed 2020·Application pending·0 cites
- 3946US11318133B2Modulators of integrated stress response pathwayPraxis Biotech LLC·Filed 2020·Granted May 3, 2022·0 cites·45 claims
- 4046US2022168313A1Heterocyclic compounds and uses thereofNUVATION BIO INC·Filed 2020·Application pending·0 cites
- 4146US2016272645A1Heterocyclic Compounds and Methods of UseMEDIVATION TECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 4245US12473262B2Aryl hydrocarbon receptor activatorsUNIV OREGON STATE·Filed 2020·Granted Nov 18, 2025·0 cites·10 claims
- 4345US2022389001A1Atf6 modulators and uses thereofPraxis Biotech LLC·Filed 2020·Application pending·0 cites
- 4444US2022169646A1Heterocyclic compounds and uses thereofNUVATION BIO INC·Filed 2020·Application pending·0 cites
- 4544US2020171030A1Dual inhibitors of alk5 and p38a map kinaseINTEGRAL BIOSCIENCES PRIVATE LTD·Filed 2019·Application pending·0 cites
- 4643US2020216417A1Inhibitors of fibroblast activation proteinPraxis Biotech LLC·Filed 2020·Application pending·0 cites
- 4742US11780821B2Inhibitors of fibroblast activation proteinPraxis Biotech LLC·Filed 2018·Granted Oct 10, 2023·0 cites·16 claims
- 4839US2020247812A1Heterocyclic compounds and methods of useINTEGRAL BIOSCIENCES PRIVATE LTD·Filed 2019·Application pending·0 cites
- 4936US2022017541A1Inhibitors of arginaseBLACK BELT TX LTD·Filed 2019·Application pending·0 cites
- 5030US10189826B2Heterocyclic compounds and methods of useMEDIVATION TECH LLC·Filed 2016·Granted Jan 29, 2019·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Brahmam Pujala files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →